Amarin Corp Plc (AMRN)

[north40000]

sstyles, I remember reading here that the GILD trial of Vascepa in the cohort of its NASH trial had been completed, but results had not been released. My memory is murky from that point—was there discussion that the treatment was not successful? Did GILD decide to abandon the 2-drug combination? GILD board, or clinical trials.gov, might give an answer.